Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus versus intravenous cyclophosphamide for severe lupus nephritis
ChiCTR-TRC-10000931Phase 4Completed
- Sponsor
- Shanghai Changzheng Hospital
- Start
- Jun 2009
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in lupus nephritis (LN) comparing Tacrolimus study arm with Cyclophosphamide control arm (2 arms). Primary endpoints: Renal biopsy pathological changes, Side effects and 1 more. Started Jun 2009; status: completed.
02
Drugs
tacrolimuscyclophosphamide
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on ChiCTR-TRC-10000931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10000931.